title: Canada's New Generic Pricing Policy: A Reasoned Approach to a Challenging Problem.
abstract: Alberta, quickly followed by other Canadian provinces, has introduced a new pricing model for generic drugs, in which prices are inversely related to the number of generic manufacturers of the drug. This paper examines the rationale for the new policy.
authors.affiliation: Professor, Department of Economics, University of Calgary, Calgary, AB.
authors.forename: Aidan
authors.initials: A
authors.lastname: Hollis
authors.affiliation: Associate Professor, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON.
authors.forename: Paul
authors.initials: P
authors.lastname: Grootendorst
mesh_terms: D002170:Canada; D003365:Costs and Cost Analysis / Q000592:standards / Q000639:trends; D004345:Drug Industry / Q000191:economics* / Q000706:statistics & numerical data; D016568:Drugs, Generic / Q000191:economics* / Q000600:supply & distribution; D006291:Health Policy / Q000191:economics* / Q000639:trends; D006801:Humans; D011306:Prescription Fees / Q000592:standards* / Q000639:trends; D012051:Reimbursement Mechanisms / Q000592:standards* / Q000639:trends
chemical_list: D016568:Drugs, Generic